直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

PTAB to Use District Court Standard for Indefiniteness

January 6, 2021

Bloomberg Law

On January 6, 2021, the U.S. Patent and Trademark Office issued a memo confirming the Nautilus approach to indefiniteness should be used to address indefiniteness in America Invents Act (AIA) post-grant proceedings. Bloomberg Law contacted Josh Goldberg for his thoughts on the guidance.

There has been confusion about which approach to indefiniteness applies to PTAB trials. The approach used during patent examination follows the In Re Packard ruling, while district courts follow the Nautilus. At the PTAB, Josh said it is not uncommon for companies to make their arguments under both approaches. He said, “The fact that now they are clarifying that we should be using Nautilus is helpful because it will allow parties to know which argument they need to be focusing on.”

Read the full article here.

Tags

indefiniteness (35 USC § 112)

Related Practices

Patent Office Invalidation Proceedings

Related Offices

Washington, DC

Related Professionals

Joshua L. Goldberg
Partner
Reston, VA
+1 202 408 6092
Email

Related News

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP